The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta-analysis.

Dian-Yu ZhengYi-Nuo WangYu-Hong HuangMin JiangYi-Nan MaCong Dai

Published in: Journal of gastroenterology and hepatology (2024)

VDZ demonstrates efficacy in skin-related EIMs like erythema nodosum and joint-related EIMs including arthritis, arthralgia, spondyloarthritis, and peripheral joint diseases. Some joint and skin-related EIMs may experience exacerbation during VDZ therapy.

Keyphrases

patients with inflammatory bowel disease
chronic obstructive pulmonary disease
rheumatoid arthritis
stem cells
soft tissue
cell therapy
acute respiratory distress syndrome